Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.

@article{Grecka2003EffectsOA,
  title={Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.},
  author={Dorota G{\'o}recka and Paweł Siwiski Sliwiński and Grzegorz Pałasiewicz and Robert Pachocki and Jan Zielinski},
  journal={Respiration; international review of thoracic diseases},
  year={2003},
  volume={70 3},
  pages={275-83}
}
BACKGROUND Advanced chronic obstructive pulmonary disease (COPD) generates high costs, especially when patients require domiciliary long-term oxygen therapy (LTOT). Almitrine bismesylate has been shown to improve gas exchange in the lungs. Our hypothesis was that long-term treatment with almitrine might postpone the prescription of LTOT. OBJECTIVE To evaluate the effects of almitrine sequential treatment on arterial blood gases in COPD patients with moderate hypoxaemia. METHODS COPD… CONTINUE READING